National Pharmacy Association (NPA) has appointed Nick Kaye as its new chair on Monday (24 April).
He has taken over the chairmanship from Andrew Lane, who stood down last month after serving his maximum term.
Nick, who part-owns Hendra Pharmacy in Cornwall will serve for two years as NPA chair, after being elected unopposed at the first meeting of the new NPA board.
Jay Badenhorst, Managing Director and Superintendent Pharmacist for Whitworth Chemists in the North East of England, is now vice-chair.
Michael Guerin, the Managing Director and Superintendent Pharmacist of the Medicare group in Northern Ireland, continues as Treasurer.
Nick Kaye said: "As a third generation community pharmacist, I feel very privileged to serve the sector that I love so dearly in this way.
"Andrew will be a hard act to follow. But I can promise my unwavering commitment to independent community pharmacy, with Jay and Michael's 's support, plus that
of board colleagues and our dedicated executive team.
Former Prime Minister Theresa May has formally opened new offices of LEO Pharma UK and Ireland during a launch event in Maidenhead, Berkshire.
The company said on Friday (June 16) that the new building, based at Foundation Park, will function as its UK and Ireland operational headquarters.
LEO Pharma has been manufacturing dermatology products in the UK and Ireland for over 60 years and continues its commitment to the Maidenhead area, where it been
based for 10 years. The grounds offer state-of-the-art facilities and a greener and more sustainable workplace, the company said and hoped that that strong transport
connections at Foundation Park will allow for seamless international collaboration, while a range of health and wellness initiatives will contribute to employee
wellbeing.
This new space will enable a collaborative and flexible work environment for LEO Pharma staff, ensuring they can continue to work to improve the lives of people
living with skin conditions, their families and society.
American healthcare technology company Omnicell has appointed Edward Platt as the new Senior Commercial Director of its UK community pharmacy division.
Along with this new role, Edward, who joined Omnicell in 2015, will continue his current leadership remit for Omnicell's UK & Ireland hospital division.
He will be leading a revamped commercial team, which would be responsible for increasing Omnicell's footprint of automation and consumable solutions delivered into
UK community pharmacies.
As part of the revamp, the company has created dedicated specialist teams to ensure the needs and challenges of community pharmacists (small independents and small
multiple operators) can be fully understood and supported.
Community Development and Health Network (CDHN) in Northern Ireland has announced that eight applicants were selected in the latest round of Level One funding for the Building the Community-Pharmacy Partnership (BCPP) programme.
Funded by Northern Ireland's Health and Social Care Board, BCCP supports communities and community pharmacists to work in partnership to address the social
determinants of health and health inequalities.
"The projects will engage across the life course working with new parents, young men and older people to empower them to take control of issues affecting their health and wellbeing. Covid recovery remains a common theme across all applications, as communities focus on addressing the impact of the pandemic on social isolation, physical and mental health."
Applications for the Level Two funding of the BCCP's Round 42 will close on 24 March 2022. For information on the programme or for some support with your application, please contact a member of the BCPP team on 028 3026 4606.
The Royal Pharmaceutical Society (RPS) has confirmed it will respond to UK Commission's 'call for evidence' on pharmacy professional leadership.
The commission wants to ensure the professions are well equipped, with a voice to help shape the future, and enabled to develop through sharing and learning from
best practice.
The UK Commission on Pharmacy Professional Leadership has been set up by the chief pharmaceutical officers of England, Scotland, Wales and Northern Ireland. It will
produce recommendations for the future of pharmacy professional leadership in the UK.
The commission is co-chaired by Nigel Clarke, former chair of the General Pharmaceutical Council, and Professor Dame Jane Dacre, professor of medical education at
University College London's Medical School.
The commission will be hosting a webinar and has urged the associations and individuals to take part in 'call for evidence' which has been launched to inform and
develop its work.
A webinar in England will take place on Wednesday 7 September 6:30 - 8 pm. In Scotland it will be organised on Tuesday 6 September 7-8:30 pm and in Wales it will be
hosted on Thursday 8 September 7-8:30 pm.
The University of Oxford's Centre for Research Equity (CfRE) has entered into a historic partnership with the Health and Social Care Research and
Development (HSC R&D) Division in Northern Ireland to advance health equity across the region and ensure everyone benefits from healthcare advancements.
Unveiled during an event at Parliament Buildings in Stormont Estate on Wednesday, this groundbreaking partnership makes Northern Ireland the first UK region
to partner with CfRE.
Supported by the Department of Health Northern Ireland and key health and social care agencies, the partnership aims to improve health outcomes and reduce
disparities through collaborative research.
Northern Ireland's Health Minister, Mike Nesbitt, highlighted that this new partnership represents "a significant step forward in efforts to address health
inequalities" in the region.
"By bringing together leading experts and resources from across sectors, we can work towards conducting research that truly benefits all of our communities," he
said.
The primary responsibility of community pharmacists is taking care of their patients but to do that they also need to learn how to run the business. It is one
thing to be au fait with profit and loss statements, reimbursement models, budgets analysis, business planning and so much more but quite another when one is hard
pressed on everything - time, resources and cash flow.
Bas Vorsteveld - the new vice president and general manager in Great Britain & Ireland for Haleon, a new company 100 per cent focussed on consumer healthcare - has
witnessed first-hand how "time poor" pharmacists usually are and is committed to helping ease their burden wherever possible.
"They can be drowning in work at all times throughout the day. If I happen to spot a community pharmacy while I am out shopping with the family, I almost always pop
into the store, with obviously a lot of questions in my head. If the pharmacist has the time, I ask them a few questions and once we start the conversation and they
find out that I'm the general manager for a company that provides them with some of their big brand products, I often get a look of total surprise on their face,
especially as I've come to visit their store and take the time to speak with them personally. I've really seen first-hand what a busy bunch they are!
"I often want to know how the shop front is presented? What does the pharmacy look like from inside? Is there a big queue? What kind of advertisement the pharmacy
has in place? How are our products merchandised?
Paul Rees MBE has joined the National Pharmacy Association (NPA) today (27 November) as its new Chief Executive.
Current NPA Chief Executive Mark Lyonette, who is retiring, will remain at the NPA for some weeks in order to ensure a smooth handover.
Previously, Paul has worked as the Chief Executive of the Royal College of Psychiatrists for the seven years.
On joining NPA, Paul said: "It is a great privilege and honour to take up the position of NPA Chief Executive. The association is the voice of independent
community pharmacy and is core to the sector's future success in England, Scotland, Wales and Northern Ireland.
"I am delighted that the NPA has placed its trust in me and I intend to deliver for NPA members, for the sector and for society at large, which relies on there
being a vibrant community pharmacy network in villages, towns and cities across the four nations of the UK."
When Paul's appointment was first announced in September, NPA Chair Nick Kaye said that they identified him as an "excellent fit for our organisation" after a
rigorous recruitment process, and also thanked Mark for his "great work as chief exec since 2018."
New legislative orders approved by the Privy Council will give the General Pharmaceutical Council (GPhC) and Pharmaceutical Society of Northern Ireland (PSNI)
powers to set professional standards for Responsible Pharmacists, Superintendent Pharmacists and Chief Pharmacists.
The Pharmacy (Preparation and Dispensing Errors - Hospital (and Other Pharmacy Services) Order 2022 and the Pharmacy (Responsible Pharmacists, Superintendent
Pharmacists etc.) Order 2022 have been published and are expected to come into force in December 2022.
Trevor Patterson, Chief Executive of the Pharmaceutical Society NI said: "We have been working with our colleagues in the GPhC and Government for some time on these
two pieces of important legislation and we are delighted they have now reached the statute books.
"Both Orders enable and enhance the powers we, and the GPhC, have to define the roles and responsibilities of Responsible, Superintendent and Chief Pharmacists,
respectively. They also create protections against criminal prosecution for hospital pharmacists where an inadvertent error is made either in dispensing or assembly,
in certain defined circumstances, similar to the protections available to colleagues working in community/registered pharmacy settings. Provisions that allow the
appointment of a Deputy Registrar for our organisation will also be introduced.
A community pharmacist was applauded for his 'quick-thinking' action in treating a Co Down woman with a fatal bee sting.
Joan Johnson, from Moira, was stung on her scalp in her home garden. After the bite, she noticed allergic reactions on her neck and ears with severe itching
and redness.
However, she was advised to visit her local pharmacy by the GP where the pharmacist, Stephen Joyce, quickly administered life-saving antihistamine and an
adrenaline injection while an ambulance was called.
Joan hailed the 'treatment' and the 'professionalism' of the whole team for saving her life.
"What was just a simple bee-sting, quickly became something very serious. On arrival at the pharmacy on the advice from my GP, I was dealt with very promptly
and Stephen was summoned and immediately took control of the situation.
"I was given an urgent antihistamine, but quickly started feeling lightheaded and faint. The pharmacy team assisted me to a chair and called an
ambulance," she said.
Boots UK has agreed to grant a five per cent pay increase to its pharmacists following a collaborative agreement with the Pharmacists' Defence
Association (PDA). This raise acknowledges the unique market conditions faced by pharmacists in the community pharmacy sector, Boots UK and PDA said in a
joint statement on Oct. 9.
According to the statement, the pay increase applies to all pharmacists within the PDA Union's bargaining unit, except for those who joined or received a pay
raise after August 2023. Moreover, trainee pharmacists or those not meeting performance standards are not eligible for the raise.
Additionally, pharmacists and store managers will receive a pro-rata, one-time non-consolidated payment of £750 in August 2024. This payment serves as recognition
for their dedication to establishing and providing new core and advanced NHS services, particularly in light of the substantial changes anticipated in the upcoming
year, the joint statement said.
The services include new medicines, hypertension, contraception, and common conditions services in England, the clinical community pharmacy service in Wales, and
the Pharmacy First services in Scotland and Northern Ireland.
As part of its centenary celebrations, the National Pharmacy Association (NPA) has raised more than eleven thousand pounds for mental health charity Mind.
A total of £11,583 was raised for Mind and the Association continues to encourage members to support the charity.
The NPA marked its 100th birthday in 2021 and partnered with Mind in England and Wales, and equivalent charities in Scotland and Northern Ireland - SAMH (Scottish Association for Mental Health) and Inspire Wellbeing - to raise awareness of pharmacy services for people with mental health problems and to generate funds for the work of these charities.
The NPA held set-piece events, such as sponsored walks, and pharmacists, colleagues and their families and friends were encouraged to organise their own activities.
Chief executive of the NPA, Mark Lyonette, said: "I was delighted to be at our sponsored walk in St Albans, home of our head office, last year. This and other fundraising events all underlined the message that community pharmacies are concerned with the wellbeing of the whole person - mind as well as body."
A new legislation has been introduced to allow authorised pharmacists along with other healthcare professionals in Northern Ireland to certify 'fit notes',
health minister Robin Swann has announced.
Pharmacists and some other healthcare professionals in England, Scotland and Wales are already allowed to sign 'fit notes'.
Swann announced that 'fit notes' were also set to go fully digital in the future, meaning they would no longer need to be signed in ink.
He said: "I am delighted to introduce this legislation in Northern Ireland. This change will make it easier for people and employers to get the advice they need so
people can stay in work and will help free up doctors' time.
"Too often we see people being faced with unnecessary challenges to get a fit note. More professionals being able to offer this vital service will speed up the
process and support people to return to or remain in work."
To help stop the pharmacists pay delay in Northern Ireland, the Pharmacists' Defence Association (PDA) will present a motion on fairer pay to the ICTU
Biennial Delegate Conference, taking place from 5 to 7 July.
The PDA motion states, "…there are other employers within the health system, that echo Agenda for Change terms, despite the fact they are essentially private
businesses contracted to the NHS, not actually public bodies. While echoing the pay structure has some advantages, these employers also seek to unnecessarily
delay pay increases on the basis that the NHS changes are so delayed.
The Universities in Ulster Schools of Pharmacy are ranked as some of the highest in the UK. They are gifting our population with high calibre graduates destined
to provide excellent patient care. These pharmacists want to stay in a job that helps patients. They want to deliver the care that they have spent years of time
and often thousands of pounds to render themselves confident and capable."
Almost nine in ten community pharmacists in England say they have patients who sometimes go without prescription medicines because they cannot afford the
prescription charge levied by the government.
Sixty-eight per cent of pharmacists in a National Pharmacy Association (NPA) survey, conducted via email in June 2022, said this has become more frequent in the
past year - suggesting that the rising cost of living could be leading more people to miss out on vital medicines.
While prescription charge does not apply in Scotland, Wales and Northern Ireland, in England an NHS patients needs to pay £9.35 per item. For patients who need
multiples medicines the cost could be exponential and virtually unaffordable amid rising inflation and higher cost of living.
The survey found that 89 per cent of pharmacies in England have patients who sometimes go without prescription medicines due to cost.
For most pharmacists (74 per cent) this happens one to five times a week. Fifteen per cent said they see such patients from six to 20 times a week.
NHS England has secured a deal for 'Dexcom ONE Real Time-Continuous Glucose Monitoring' device which will help type 1 diabetes patients to keep track of their
glucose levels at all times without having to scan or take a finger prick test.
Once the patients receive their starter pack - which will include information on the product and usage, a sensor and transmitter - from the hospital or GP surgery,
they can go to the community pharmacy for their repeat prescription.
The wearable arm gadget sends information to a mobile app and allows diabetes patients to keep track of their glucose levels.
"Traditionally, continuous glucose monitors are more expensive than their flash monitor counterparts - which record glucose levels by scanning a sensor - but thanks
to the NHS agreeing on a new cost-effective deal with manufacturers DEXCOM, they will now be available for NHS patients on prescription at a similar price," said NHS.
Dexcom ONE Real Time-Continuous Glucose Monitoring, uses a sensor no bigger than a bottle cap that attaches to the arm for up to 10 days and measures glucose levels
from just under the skin.
The wider rollout of the technology will help diabetes patients manage their condition better - reducing hospitalisations and associated diabetic illnesses which will
ultimately ease pressure off the NHS.
Karen Baxter, vice president, UK & Ireland, Benelux, France and Spain at Dexcom: "The addition of Dexcom ONE to the NHS England drug tariff is enormous progress
towards improving the choice of diabetes tech, providing an alternative to burdensome finger pricks and scanning.
Bas Vorsteveld, who was made vice president and general manager for Great Britain & Ireland (GBI) in November last year, is joined by Monica Michalopoulou as GBI marketing director and Onyeka Anugwom as GBI commercial excellence director GSK Consumer Healthcare.
He took over from Jonathan Workman, who held the position from 2018, and has now moved into the role of Business Unit general manager for Northern Europe.
Vorsteveld, who has 15 years' industry experience, played at major part in the merger of Novartis and GSK consumer healthcare businesses. Most recently, he held
the role of VP & head of commercial excellence EMEA LATAM at GSK Consumer Healthcare, where he spearheaded international sustainability initiatives.
Commenting on his new role, Vorsteveld said: "I am incredibly honoured to have been a part of GSK Consumer Healthcare's journey to date and it is our collective ambition to deliver better everyday health with humanity for our customers, with a laser focus on 'self-care'.
"The recent pandemic has shown us that healthcare matters more now than ever before for our consumers. We want to redefine the role that self-care plays in people's lives, because it can bring long-term benefits for individuals and society, and is a key component of a sustainable healthcare system.